Oculis Holding AG (OCS) Interest & Investment Income (2022 - 2026)
Powered by 
Analysis
Oculis Holding AG (OCS) Interest & Investment Income (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Oculis Holding AG | 634.75 Mn | 345.87 Mn | - | 749,021.55 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 749,021.55 |
| Mar 31, 2026 | 468,660.72 |
| Dec 31, 2025 | 399,123.16 |
| Sep 30, 2025 | 547,547.97 |
| Jun 30, 2025 | 628,102.92 |
| Mar 31, 2025 | 548,339.51 |
| Dec 31, 2024 | 423,504.61 |
| Sep 30, 2024 | 641,739.23 |
| Jun 30, 2024 | 729,823.70 |
| Mar 31, 2024 | 665,641.42 |
| Dec 31, 2023 | 739,544.53 |
| Sep 30, 2023 | 588,719.33 |
| Jun 30, 2023 | 240,229.92 |
| Mar 31, 2023 | 35,678.37 |
| Dec 31, 2022 | 58,129.23 |
| Sep 30, 2022 | 63,162.85 |
| Jun 30, 2022 | 7,268.05 |